Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrapulmonary concentrations of antimicrobial agents

D E Nix1

  • 1Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, USA.

Infectious Disease Clinics of North America
|October 21, 1998
PubMed
Summary

Measuring antimicrobial drug concentrations in the lungs is crucial for treating infections. Further research is needed to link these drug levels to treatment success or failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditions.

The Annals of pharmacotherapy·2001
Same author

Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids.

Pharmacotherapy·2001
Same author

In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.

Diagnostic microbiology and infectious disease·2001
Same author

Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids.

Antimicrobial agents and chemotherapy·2001
Same author

Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.

The Journal of trauma·2000
Same author

Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·1999

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Effective antimicrobial therapy requires adequate drug concentrations at the infection site.
  • Lower respiratory tract infections commonly affect the bronchial mucosa, endothelial lining fluid, and alveolar macrophages.
  • Accurate measurement of antimicrobial drug levels within lung tissues is essential for optimizing treatment.

Purpose of the Study:

  • To review the theoretical basis and methodologies for measuring antimicrobial agent delivery within the lungs.
  • To compare the intrapulmonary delivery of commonly used antimicrobial agents for lower respiratory tract infections.

Main Methods:

  • Review of existing literature on antimicrobial pharmacokinetics in lung tissues.
  • Analysis of methods for quantifying drug concentrations in bronchial mucosa, epithelial lining fluid, and alveolar macrophages.
  • Comparative analysis of intrapulmonary drug delivery profiles for various antimicrobial agents.

Main Results:

  • Advances in measuring antimicrobial concentrations at intrapulmonary sites have been made.
  • Current methods for measuring drug concentrations in lung tissues require further refinement and standardization.
  • The relationship between intrapulmonary antimicrobial concentrations and clinical outcomes (efficacy or treatment failure) requires additional investigation.

Conclusions:

  • Optimizing antimicrobial delivery to lung tissues is critical for treating respiratory infections.
  • Standardization of measurement techniques is needed to accurately assess intrapulmonary drug concentrations.
  • Further studies are essential to correlate intrapulmonary antimicrobial levels with treatment efficacy.

Related Experiment Videos